r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

RI

Robert Iannone

Insider · EVP, Global Head of R&D & CMO · JAZZ

Robert Iannone files insider transactions with the SEC as an evp, global head of r&d & cmo of Jazz Pharmaceuticals (JAZZ). We hold 1 disclosed purchase or sale filed since 18 September 2018, 1 of them in the last 90 days.

  • Files forJAZZ
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure31 August 2026

Positions held

6 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 8 August 2019 — 27 August 2026EVP, Global Head of R&D & CMO · Jazz Pharmaceuticals (JAZZ)53 Form 4 lines · source: SEC Form 4
  • Filed 9 July 2026 — 9 July 2026Director · Pliant Therapeutics (PLRX)1 Form 4 line · source: SEC Form 4
  • Filed 29 June 2026 — 29 June 2026Director · Autolus Therapeutics (AUTL)2 Form 4 lines · source: SEC Form 4
  • Filed 29 April 2021 — 11 June 2024Director · iTeos Therapeutics (ITOS)5 Form 4 lines · source: SEC Form 4
  • Filed 21 January 2020 — 3 May 2023Director · Jounce Therapeutics (JNCE)9 Form 4 lines · source: SEC Form 4
  • Filed 14 September 2018 — 14 March 2019Chief Medical Officer · Immunomedics (IMMU)3 Form 4 lines · source: SEC Form 4

Everything they disclosed

73 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.